Project details
- Project period
- 1 Dec 2024 - 30 Nov 2028
- Total cost
- €5 736 729,64
- Global Health EDCTP3 funding
- €5 736 729,64
- Call identifier
- HORIZON_HORIZON-JU-GH-EDCTP3-2023-02-01-two-stage
- Status
- In progress
- Project type
- Research and Innovation Actions (RIA)
- Disease area
- Malaria
- Intervention type
- Vaccines
Consortium map
Coordinator
R-EVOLUTION WORLDWIDE SRL - IMPRESA SOCIALE
- Location
- MAGLIE, Italy
- EU contribution
- €296 437,50
- Total cost
- €296 437,50
Beneficiaries
UNIVERSITE DES SCIENCES DES TECHNIQUES ET DES TECHNOLOGIES DE BAMAKO
- Location
- Bamako, Mali
- EU contribution
- €1 932 071,25
- Total cost
- €1 932 071,25
EPICENTRE
- Location
- Paris, France
- EU contribution
- €1 469 570,89
- Total cost
- €1 469 570,89
CENTRE NATIONAL DE RECHERCHE SCIENTIFIQUE ET TECHNOLOGIQUE*INSTITUT DE RECHERCHE EN SCIENCES DE LA SANTE
- Location
- Ouagadougou, Burkina Faso
- EU contribution
- €2 038 650,00
- Total cost
- €2 038 650,00
Partners
LIVERPOOL SCHOOL OF TROPICAL MEDICINE
- Location
- LIVERPOOL 3, United Kingdom
Related projects
AI detection of parasite infectionsThe MultiplexAI project is developing an easy-to-use add-on for conventional microscopes that deploys artificial intelligence (AI) models to detect...
Disrupting mosquito feeding to prevent malariaThe LASR project is testing whether a newly developed mosquito repellent can reduce the community burden of malaria infections.
The overall goal of this project is to provide scientific evidence for WHO policymaking on the longterm efficacy, safety, acceptability and cost-effectiveness of using R21/Matrix-Malaria...